ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 170 filers reported holding ANTARES PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $225,000 | -1.3% | 54,808 | -14.1% | 0.00% | 0.0% |
| Q4 2021 | $228,000 | -47.8% | 63,777 | -47.0% | 0.00% | -33.3% |
| Q3 2021 | $437,000 | +28.2% | 120,394 | +54.0% | 0.00% | 0.0% |
| Q2 2021 | $341,000 | -23.4% | 78,195 | -27.7% | 0.00% | -25.0% |
| Q1 2021 | $445,000 | +25.4% | 108,203 | +21.7% | 0.00% | 0.0% |
| Q4 2020 | $355,000 | +27.2% | 88,938 | -13.4% | 0.00% | 0.0% |
| Q3 2020 | $279,000 | +1.8% | 102,738 | +3.0% | 0.00% | 0.0% |
| Q2 2020 | $274,000 | -6.8% | 99,738 | -19.8% | 0.00% | -20.0% |
| Q1 2020 | $294,000 | -50.3% | 124,388 | -1.3% | 0.01% | -44.4% |
| Q4 2019 | $592,000 | +40.6% | 125,988 | +0.6% | 0.01% | +28.6% |
| Q3 2019 | $421,000 | +2.2% | 125,251 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $412,000 | +31.6% | 125,251 | +21.2% | 0.01% | +16.7% |
| Q1 2019 | $313,000 | +72.9% | 103,380 | +55.7% | 0.01% | +50.0% |
| Q4 2018 | $181,000 | – | 66,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |